• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ALTL ALANINE AMINOTRANSFERASE - PYRIDOXAL PHOPHATE ACTIVATED; NADH OXIDATION/NAD REDUCTION, ALT/SGPT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ALTL ALANINE AMINOTRANSFERASE - PYRIDOXAL PHOPHATE ACTIVATED; NADH OXIDATION/NAD REDUCTION, ALT/SGPT Back to Search Results
Catalog Number 04467388190
Device Problem High Test Results (2457)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 05/18/2020
Event Type  malfunction  
Manufacturer Narrative
Sample from the patient was requested for further investigation.This event occurred in (b)(6).
 
Event Description
The initial reporter received questionable altl alanine aminotransferase and astlp aspartate aminotransferase results for one patient from cobas 6000 series system serial number (b)(4).The customer suspected an interference with the intravenous medication "monofer" (iron supplement).This medwatch is for altl.Refer to the medwatch with patient identifier (b)(6) for the astlp assay.The initial results were a "normal sample run".No specific data was provided.The repeat results with a 1:10 dilution were: altlp: 9 i/u with a data flag and 4 i/u with a data flag.Astlp: 12 i/u with a data flag and 29 i/u with a data flag.The repeat results were a 1:20 dilution were: altlp: 7 i/u with a data flag.Astlp: 13 i/u with a data flag.The repeat results were: altlp: 4 i/u with a data flag.Astlp: -13 i/u with a data flag.After the sample was recentrifuged, the results were: altlp: 8 i/u with a data flag and 10 i/u with a data flag.Astlp: 14 i/u with a data flag and 31 i/u with a data flag.The questionable results were not reported outside of the laboratory.
 
Manufacturer Narrative
The investigation did not identify a product problem.The cause of the event could not be determined.
 
Manufacturer Narrative
Testing of the returned patient sample confirmed the customer's results.The investigation could not confirm an interference with the medication monofer.As quality controls were acceptable, a general reagent issue could be excluded.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALTL ALANINE AMINOTRANSFERASE - PYRIDOXAL PHOPHATE ACTIVATED
Type of Device
NADH OXIDATION/NAD REDUCTION, ALT/SGPT
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key10138787
MDR Text Key203350085
Report Number1823260-2020-01412
Device Sequence Number1
Product Code CKA
Combination Product (y/n)N
PMA/PMN Number
K951595
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup,Followup
Report Date 09/11/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/10/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number04467388190
Device Lot Number459231
Was Device Available for Evaluation? No
Date Manufacturer Received05/18/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age47 YR
-
-